Logo image of EMX

EMX ROYALTY CORP (EMX) Stock Fundamental Analysis

NYSEARCA:EMX - CA26873J1075 - Common Stock

4.07 USD
+0.25 (+6.54%)
Last: 9/5/2025, 8:10:01 PM
4.01 USD
-0.06 (-1.47%)
After Hours: 9/5/2025, 8:10:01 PM
Fundamental Rating

5

Overall EMX gets a fundamental rating of 5 out of 10. We evaluated EMX against 156 industry peers in the Metals & Mining industry. While EMX has a great health rating, there are worries on its profitability. While showing a medium growth rate, EMX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

EMX had positive earnings in the past year.
In the past year EMX had a positive cash flow from operations.
In the past 5 years EMX reported 4 times negative net income.
In multiple years EMX reported negative operating cash flow during the last 5 years.
EMX Yearly Net Income VS EBIT VS OCF VS FCFEMX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

EMX has a Return On Assets of 3.31%. This is in the better half of the industry: EMX outperforms 70.51% of its industry peers.
The Return On Equity of EMX (4.19%) is better than 64.74% of its industry peers.
With a Return On Invested Capital value of 2.64%, EMX perfoms like the industry average, outperforming 56.41% of the companies in the same industry.
Industry RankSector Rank
ROA 3.31%
ROE 4.19%
ROIC 2.64%
ROA(3y)-1.01%
ROA(5y)-4.61%
ROE(3y)-1.33%
ROE(5y)-6.3%
ROIC(3y)N/A
ROIC(5y)N/A
EMX Yearly ROA, ROE, ROICEMX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

EMX's Profit Margin of 16.28% is amongst the best of the industry. EMX outperforms 82.05% of its industry peers.
Looking at the Operating Margin, with a value of 15.92%, EMX is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
Industry RankSector Rank
OM 15.92%
PM (TTM) 16.28%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMX Yearly Profit, Operating, Gross MarginsEMX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EMX is destroying value.
The number of shares outstanding for EMX has been reduced compared to 1 year ago.
Compared to 5 years ago, EMX has more shares outstanding
The debt/assets ratio for EMX is higher compared to a year ago.
EMX Yearly Shares OutstandingEMX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
EMX Yearly Total Debt VS Total AssetsEMX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

EMX has an Altman-Z score of 12.09. This indicates that EMX is financially healthy and has little risk of bankruptcy at the moment.
EMX's Altman-Z score of 12.09 is amongst the best of the industry. EMX outperforms 81.41% of its industry peers.
EMX has a debt to FCF ratio of 8.95. This is a slightly negative value and a sign of low solvency as EMX would need 8.95 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.95, EMX is in the better half of the industry, outperforming 64.10% of the companies in the same industry.
A Debt/Equity ratio of 0.21 indicates that EMX is not too dependend on debt financing.
EMX has a Debt to Equity ratio (0.21) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 8.95
Altman-Z 12.09
ROIC/WACC0.28
WACC9.55%
EMX Yearly LT Debt VS Equity VS FCFEMX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 7.86 indicates that EMX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 7.86, EMX belongs to the top of the industry, outperforming 89.10% of the companies in the same industry.
A Quick Ratio of 7.86 indicates that EMX has no problem at all paying its short term obligations.
EMX has a better Quick ratio (7.86) than 89.74% of its industry peers.
Industry RankSector Rank
Current Ratio 7.86
Quick Ratio 7.86
EMX Yearly Current Assets VS Current LiabilitesEMX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 305.16% over the past year.
The Revenue has decreased by -8.72% in the past year.
Measured over the past years, EMX shows a very strong growth in Revenue. The Revenue has been growing by 40.11% on average per year.
EPS 1Y (TTM)305.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.19%
Revenue 1Y (TTM)-8.72%
Revenue growth 3Y42.76%
Revenue growth 5Y40.11%
Sales Q2Q%4.05%

3.2 Future

Based on estimates for the next years, EMX will show a very strong growth in Earnings Per Share. The EPS will grow by 71.00% on average per year.
The Revenue is expected to grow by 10.78% on average over the next years. This is quite good.
EPS Next Y233.33%
EPS Next 2Y100%
EPS Next 3Y71%
EPS Next 5YN/A
Revenue Next Year15.63%
Revenue Next 2Y9.51%
Revenue Next 3Y10.78%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
EMX Yearly Revenue VS EstimatesEMX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
EMX Yearly EPS VS EstimatesEMX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 -0.1 -0.15

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 135.67, EMX can be considered very expensive at the moment.
EMX's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.06. EMX is valued rather expensively when compared to this.
EMX is valuated quite expensively with a Price/Forward Earnings ratio of 90.86.
The rest of the industry has a similar Price/Forward Earnings ratio as EMX.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.69, EMX is valued quite expensively.
Industry RankSector Rank
PE 135.67
Fwd PE 90.86
EMX Price Earnings VS Forward Price EarningsEMX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

EMX's Enterprise Value to EBITDA is on the same level as the industry average.
EMX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 222.94
EV/EBITDA 56.06
EMX Per share dataEMX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6

4.3 Compensation for Growth

EMX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as EMX's earnings are expected to grow with 71.00% in the coming years.
PEG (NY)0.58
PEG (5Y)N/A
EPS Next 2Y100%
EPS Next 3Y71%

0

5. Dividend

5.1 Amount

EMX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EMX ROYALTY CORP

NYSEARCA:EMX (9/5/2025, 8:10:01 PM)

After market: 4.01 -0.06 (-1.47%)

4.07

+0.25 (+6.54%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-05 2025-11-05
Inst Owners17.57%
Inst Owner Change50.29%
Ins Owners14.98%
Ins Owner ChangeN/A
Market Cap444.36M
Analysts84.44
Price Target4.26 (4.67%)
Short Float %0.16%
Short Ratio0.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)116.51%
Min EPS beat(2)35.92%
Max EPS beat(2)197.09%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)21.11%
PT rev (3m)21.38%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)33.33%
EPS NY rev (3m)33.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)3.5%
Revenue NY rev (3m)25.42%
Valuation
Industry RankSector Rank
PE 135.67
Fwd PE 90.86
P/S 20.53
P/FCF 222.94
P/OCF 42.32
P/B 5.28
P/tB 5.28
EV/EBITDA 56.06
EPS(TTM)0.03
EY0.74%
EPS(NY)0.04
Fwd EY1.1%
FCF(TTM)0.02
FCFY0.45%
OCF(TTM)0.1
OCFY2.36%
SpS0.2
BVpS0.77
TBVpS0.77
PEG (NY)0.58
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.31%
ROE 4.19%
ROCE 3.34%
ROIC 2.64%
ROICexc 3.17%
ROICexgc 3.17%
OM 15.92%
PM (TTM) 16.28%
GM N/A
FCFM 9.21%
ROA(3y)-1.01%
ROA(5y)-4.61%
ROE(3y)-1.33%
ROE(5y)-6.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 8.95
Debt/EBITDA 2.27
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.84
Cash Conversion 133.77%
Profit Quality 56.55%
Current Ratio 7.86
Quick Ratio 7.86
Altman-Z 12.09
F-Score7
WACC9.55%
ROIC/WACC0.28
Cap/Depr(3y)25.77%
Cap/Depr(5y)19.56%
Cap/Sales(3y)6.62%
Cap/Sales(5y)4.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)305.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.19%
EPS Next Y233.33%
EPS Next 2Y100%
EPS Next 3Y71%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.72%
Revenue growth 3Y42.76%
Revenue growth 5Y40.11%
Sales Q2Q%4.05%
Revenue Next Year15.63%
Revenue Next 2Y9.51%
Revenue Next 3Y10.78%
Revenue Next 5YN/A
EBIT growth 1Y0.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3054.64%
EBIT Next 3Y239.73%
EBIT Next 5YN/A
FCF growth 1Y179.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y622.77%
OCF growth 3YN/A
OCF growth 5YN/A